Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3,800.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 4,100.00
  • 52 Week Low: 2,750.00
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 1,010
  • Market Cap: £195.42m
  • Beta: 0.00

Latest ShareCast News

Vitamin D antibodies drive first-half growth at Bioventix

By Josh White

Date: Friday 29 Mar 2019

(Sharecast News) - Monoclonal antibodies developer and supplier Bioventix reported a 24% improvement in its normalised revenue in its half-year report on Friday, to £4.4m.

Bioventix posts healthy profits, ups dividend; warns of plateauing vit-D sales

By Abigail Townsend

Date: Monday 08 Oct 2018

(Sharecast News) - Aim's Bioventix announced Monday it would pay a special dividend after a strong year of revenue and profit growth - but also sounded a warning over one of its key revenue streams.

Bioventix ups dividend on improved profits

By Iain Gilbert

Date: Monday 26 Mar 2018

(ShareCast News) - AIM-quoted pharmaceuticals company Bioventix saw revenues and profits move ahead in the first half of its trading year, leading the company to boost its first interim dividend by 20%.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,800.00p
Change Today -10.00p
% Change -0.26 %
52 Week High 4,100.00
52 Week Low 2,750.00
Volume 1,010
Shares Issued 5.14m
Market Cap £195.42m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.59% below the market average83.59% below the market average83.59% below the market average83.59% below the market average83.59% below the market average
93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average93.1% below the sector average
Price Trend
77.90% above the market average77.90% above the market average77.90% above the market average77.90% above the market average77.90% above the market average
55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average55.93% above the sector average
Income
30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average30.53% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
Growth
45.57% above the market average45.57% above the market average45.57% above the market average45.57% above the market average45.57% above the market average
72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average72.97% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 11-Apr-19 25-Oct-18
Paid 26-Apr-19 09-Nov-18
Amount 30.00p 36.00p

Trades for 20-Sep-2019

Time Volume / Share Price
14:04 3 @ 3,800.00p
11:43 500 @ 3,750.00p
08:43 507 @ 3,770.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page